Smartinhaler manufacturer Adherium Limited has appointed Arik Anderson as Group CEO, the company said. He succeeds company founder Garth Sutherland, who will stay on as an Executive Director on the board. Anderson, who was most recently President of Perfusion and Surgical Devices at Terumo Cardiovascular Systems, has more than 25 years of experience working at … [Read more...] about Adherium appoints Arik Anderson as Group CEO
People
MannKind announces new CEO, Brazilian distribution deal for Afrezza
MannKind Corporation has announced the appointment of Michael Castagna as Chief Executive Officer, effective May 25, 2017. Castagna takes over the role from Matthew Pfeffer, who succeeded Alfred Mann as CEO in January 2016. Pfeffer had also served as CFO, a role that will now be filled on an interim basis by Rose Alinaya, who is currently the company's Senior VP … [Read more...] about MannKind announces new CEO, Brazilian distribution deal for Afrezza
Therapix Biosciences to look for US-based CEO
Elran Haber, CEO of Therapix Biosciences, which is developing intranasal cannabinoid-based drugs, will step down "to pursue other professional opportunities" after the company concludes its search for "a permanent, US based Chief Executive Officer," the company said. Over the past year, the Israeli company has licensed both an intranasal cannabinoid formulation … [Read more...] about Therapix Biosciences to look for US-based CEO
Insmed announces management appointments
Arikayce inhaled amikacin deveoper Insmed Incorporated has announced the appointments of Paolo Tombesi as Chief Financial Officer, Paul Streck as Chief Medical Officer, and Eugene Sullivan as Chief Product Strategy Officer. Tombesi was most recently VP and Chief Financial and Administrative Officer of Novartis Pharmaceuticals Corporation, and Streck was most … [Read more...] about Insmed announces management appointments
Pulmatrix appoints Ted Raad as Chief Business Officer
Inhaled drug developer Pulmatrix has announced the appointment of former Sunovion Respiratory and CNS Business Unit Head Ted Raad as Chief Business Officer. Raad was most recently Chief Commercial Officer at Option Care, the home infusion services subsidiary of Walgreens. Pulmatrix CEO Robert Clarke said, "Ted is a proven leader in the commercial development of … [Read more...] about Pulmatrix appoints Ted Raad as Chief Business Officer
Cohero announces the appointment of Joe Condurso as CEO
Digital health company Cohero Health has announced the appointment of Joe Condurso as CEO. Cohero and its partner Presspart introduced their eMDI smart inhaler system at DDL in 2016. Condurso was most recently CEO of PatientSafe Solutions and previously worked at CareFusion (now Becton Dickinson) and a number of other medical companies over a 30-year … [Read more...] about Cohero announces the appointment of Joe Condurso as CEO
Verona Pharma announces development agreements, appointment of Richard Hennings as Commercial Director
Verona Pharma has announced a clinical development services agreement with QuintilesIMS for Verona's RPL554, an inhaled PDE3/PDE4 inhibitor for the treatment of acute exacerbations in COPD patients. The company also said that it is planning to develop RPL554 as both an MDI and as a DPI in partnership with two European technology companies. In addition, Verona … [Read more...] about Verona Pharma announces development agreements, appointment of Richard Hennings as Commercial Director
MVIC announces new CEO, new member company, new services
The Medicon Valley Inhalation Consortium (MVIC) has announced that Lars Asking, who has served as VP of MVIC since May 2016, will become CEO of the consortium as of May 2017. Asking will take over the role from Ola Nerbrink who will continue as VP Business Development. Nerbrink succeeded Orest Lastow as CEO of MVIC in 2014. In addition, MVIC said that AB I Lamberg … [Read more...] about MVIC announces new CEO, new member company, new services
Milestone Pharmaceuticals appoints Joseph G. Oliveto as President and CEO
Milestone Pharmaceuticals has announced the appointment of Joseph G. Oliveto as President and CEO. Oliveto, who was most recently CEO of Galleon Pharmaceuticals and previously served as President and CEO of Chelsea Therapeutics, is replacing company founder Phillippe Douville, who is now Chief Scientific Officer. Milestone's lead candidate, etripamil is an … [Read more...] about Milestone Pharmaceuticals appoints Joseph G. Oliveto as President and CEO
Timothy S. Nelson joins the board of Impel NeuroPharma
Intranasal drug developer Impel NeuroPharma has announced the appointment of former MAP Pharmaceuticals President and CEO Timothy S. Nelson as Independent Director of the Board of Directors. Nelson led MAP Pharmaceuticals when it was acquired by Allergan and served as Chairman of the Board of Civitas Therapeutics when that company was acquired by Acorda. MAP … [Read more...] about Timothy S. Nelson joins the board of Impel NeuroPharma